Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Stock Shanghai S.E.
Equities
600332
CNE000001733
Pharmaceuticals
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
31.32 CNY | -0.13% | +3.26% | +9.51% |
Sales 2024 * | 80.8B 11.15B | Sales 2025 * | 85.61B 11.81B | Capitalization | 48.19B 6.65B |
---|---|---|---|---|---|
Net income 2024 * | 4.17B 576M | Net income 2025 * | 4.44B 612M | EV / Sales 2024 * | 0.36 x |
Net cash position 2024 * | 19.18B 2.65B | Net cash position 2025 * | 22.46B 3.1B | EV / Sales 2025 * | 0.3 x |
P/E ratio 2024 * |
7.59
x | P/E ratio 2025 * |
7.3
x | Employees | 28,048 |
Yield 2024 * |
4.25% | Yield 2025 * |
4.51% | Free-Float | 49.33% |
1 day | -0.13% | ||
1 week | +3.26% | ||
Current month | +8.56% | ||
1 month | +8.49% | ||
3 months | +14.60% | ||
6 months | +10.67% | ||
Current year | +9.51% |
Managers | Title | Age | Since |
---|---|---|---|
Hong Li
CEO | Chief Executive Officer | 57 | 17-06-22 |
Rui Yu Cai
CHM | Chairman | 57 | - |
Chun Bo Zhang
BRD | Director/Board Member | 47 | 14-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Lung Tak Wong
BRD | Director/Board Member | 76 | 10-06-27 |
Chu Yuan Li
CHM | Chairman | 58 | 10-06-27 |
Chang Hai Wu
BRD | Director/Board Member | 58 | 10-06-27 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.72% | 2 M€ | -19.10% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-24 | 31.32 | -0.13% | 7,565,233 |
24-04-23 | 31.36 | -0.60% | 9,698,877 |
24-04-22 | 31.55 | +0.03% | 15,817,680 |
24-04-19 | 31.54 | +2.74% | 17,208,600 |
24-04-18 | 30.7 | +1.22% | 14,583,420 |
End-of-day quote Shanghai S.E., April 23, 2024
More quotesEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+25.61% | 660B | |
+23.05% | 562B | |
-5.24% | 358B | |
+16.49% | 322B | |
+8.28% | 297B | |
+12.79% | 219B | |
-9.61% | 196B | |
+6.72% | 199B | |
-8.75% | 149B |
- Stock Market
- Equities
- 874 Stock
- 600332 Stock